M
Moreno Ursino
Researcher at University of Paris
Publications - 44
Citations - 368
Moreno Ursino is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 9, co-authored 34 publications receiving 206 citations. Previous affiliations of Moreno Ursino include French Institute for Research in Computer Science and Automation & Paris Descartes University.
Papers
More filters
Journal ArticleDOI
Association Between Early Invasive Mechanical Ventilation and Day-60 Mortality in Acute Hypoxemic Respiratory Failure Related to Coronavirus Disease-2019 Pneumonia
Claire Dupuis,Lila Bouadma,Lila Bouadma,Etienne de Montmollin,Etienne de Montmollin,Dany Goldgran-Toledano,Carole Schwebel,Jean Reignier,Mathilde Neuville,Moreno Ursino,Shidasp Siami,Stéphane Ruckly,Corinne Alberti,Bruno Mourvillier,Sébastien Bailly,Kévin Grapin,Virginie Laurent,Niccolò Buetti,Marc Gainnier,Bertrand Souweine,Jean-François Timsit,Jean-François Timsit +21 more
TL;DR: In this paper, the effect of early invasive mechanical ventilation in patients with acute hypoxemic respiratory failure on day-60 mortality was investigated in a multicenter prospective French observational study.
Journal ArticleDOI
Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populations.
Moreno Ursino,Sarah Zohar,Frederike Lentz,Corinne Alberti,Tim Friede,Nigel Stallard,Emmanuelle Comets,Emmanuelle Comets +7 more
TL;DR: Using PK information in the dose allocation process enriches the knowledge of the dose‐toxicity relationship, facilitating better dose recommendation for subsequent trials and improving the efficiency of dose‐finding trials.
Journal ArticleDOI
Recent advances in methodology for clinical trials in small populations: the InSPiRe project
Tim Friede,Martin Posch,Sarah Zohar,Corinne Alberti,Norbert Benda,Emmanuelle Comets,Emmanuelle Comets,Simon Day,Alex Dmitrienko,Alexandra Graf,Burak Kürsad Günhan,Siew Wan Hee,Frederike Lentz,Jason Madan,Frank Miller,Thomas Ondra,Michael Pearce,Christian Röver,Artemis Toumazi,Steffen Unkel,Moreno Ursino,Gernot Wassmer,Nigel Stallard +22 more
TL;DR: The InSPiRe project has led to development of novel statistical methodology for clinical trials in small populations in four areas, including new decision-making methods for small population clinical trials using a Bayesian decision-theoretic framework.
Journal ArticleDOI
Recent advances in methodology for clinical trials in small populations: the InSPiRe project
Tim Friede,Martin Posch,Sarah Zohar,Corinne Alberti,Norbert Benda,Emmanuelle Comets,Simon Day,A. Dmitrenko,Alexandra Graf,Burak Kürsad Günhan,Siew Wan Hee,Frederike Lentz,Jason Madan,Frank Miller,Thomas Ondra,Michael Pearce,Christian Röver,A. Tournazi,Steffen Unkel,Moreno Ursino,Gernot Wassmer,Nigel Stallard +21 more
TL;DR: The InSPiRe project as discussed by the authors developed decision-making methods for small population clinical trials using a Bayesian decision-theoretic framework to compare costs with potential benefits, developed approaches for targeted treatment trials, enabling simultaneous identification of subgroups and confirmation of treatment effect for these patients, worked on early phase clinical trial design and on extrapolation from adult to pediatric studies, developing methods to enable use of pharmacokinetics and pharmacodynamics data, and also developed improved robust meta-analysis methods for a small number of trials to support the planning, analysis and interpretation of a trial as
Journal ArticleDOI
Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network.
Claire Dupuis,Etienne de Montmollin,Etienne de Montmollin,Niccolò Buetti,Dany Goldgran-Toledano,Jean Reignier,Carole Schwebel,Julien Domitile,Mathilde Neuville,Moreno Ursino,Shidasp Siami,Stéphane Ruckly,Corinne Alberti,Bruno Mourvillier,Sébastien Bailly,Virginie Laurent,Marc Gainnier,Bertrand Souweine,Jean-François Timsit,Jean-François Timsit +19 more
TL;DR: For patients with COVID-19 pneumonia, early CS treatment was not associated with patient survival, suggesting inflammation and age can significantly influence the effect of CS.